Dr Reddys Selected Fundamentals

RDY -- USA Stock  

USD 37.41  0.07  0.19%

Dr Reddys fundamental analysis lookup allows you to check this and other indicators for Dr Reddys Laboratories Ltd or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Dr Reddys Price to Earnings To Growth Analysis

PEG Ratio indicates potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate.Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates future growth of a firm. The low PEG ratio usually implies that equity instrument is undervalued; where as PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
PEG Ratio 
 = 
PE Ratio 
EPS Growth 
More About Price to Earnings To Growth | All Equity Analysis
Dr Reddys Price to Earnings To Growth  =
1.66 
Dr Reddys ValuationFundamentalsBuy or Sell

About Price to Earnings To Growth

Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Compare to competition
Based on latest financial disclosure the price to earnings to growth indicator of Dr Reddys Laboratories Ltd is roughly 1.66 times. This is 133.8% higher than that of the Healthcare sector, and 74.74% higher than that of Drug Manufacturers - Specialty & Generic industry, The Price to Earnings To Growth for all stocks is 66.05% higher than the company.

Dr Reddys Laboratories Fundamental Drivers Relationships

Dr Reddys Laboratories Ltd is rated fifth in book value per share category among related companies. It is rated fifth in cash and equivalents category among related companies creating about  24,495,246  of Cash and Equivalents per Book Value Per Share.

Dr Reddys Cash and Equivalents Peer Comparison

  Cash and Equivalents 
      Dr Reddys Comparables 
Dr Reddys is rated fourth in cash and equivalents category among related companies.

Dr Reddys current financial ratios



 
Search macroaxis.com